Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2015 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2015 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis

  • Authors:
    • Wei Ji
    • Yajun Chen
    • Xia Zhao
    • Yunke Guo
    • Lingyu Zhong
    • Honggang Li
    • Dan Wang
    • Yanna Song
  • View Affiliations / Copyright

    Affiliations: Department of Rheumatology, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China, Department of Rheumatology and Immunology, Zhuzhou City Hospital, Zhuzhou, Hunan 412000, P.R. China, Department of Tuberculosis, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China, Department of Immunity, Nanjing Jiangbei People's Hospital, Nanjing, Jiangsu 210048, P.R. China
  • Pages: 684-690
    |
    Published online on: March 6, 2015
       https://doi.org/10.3892/mmr.2015.3448
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the current study was to explore the effects and possible mechanisms of tripterygium glycosides tablet (TGT) in the treatment of active ankylosing spondylitis (AS). Thirty‑six patients with active AS were given a 20 mg TGT treatment three times per day for 12 weeks, and 21 unrelated healthy controls were recruited as the control group. Efficacy measures included the Bath AS disease activity index (BASDAI), erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) prior and subsequent to TGT treatment. Serum dickkopf homolog 1 (DKK1) and interleukin-17 (IL‑17) levels before and after TGT treatment were assessed using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and ELISA assay. The levels of several serum biomarkers were determined by ELISA, including receptor activator of nuclear factor κ‑B ligand (RANKL), osteoprotegerin (OPG), bone alkaline phosphatase (BAP), bone morphogenetic protein‑2 (BMP‑2), matrix metalloproteinase‑3 (MMP‑3), cross‑linked telopeptide of type II collagen (CTX‑II), vascular endothelial growth factor (VEGF), and prostaglandin E2 (PGE2). After 12 weeks of TGT treatment, the BASDAI score of the patients was significantly reduced (P<0.05), their levels of ESR and CRP were significantly reduced to a normal level (P<0.05, P<0.05), RT‑PCR and ELISA showed a significant increase in the level of DKK1 expression (P<0.05) and a significant decreased IL‑17 expression (P<0.05), there was a significant increase in the expression of OPG, BAP and BMP‑2 (P<0.01, P<0.01, P<0.01) and a significant reduction in the expression levels of RANKL, CTX‑II. MMP‑3, PGE2, and VEGF (P<0.01, P<0.01, P<0.01, P<0.05, P<0.01) compared with those of the controls. TGT is effective at improving the signs and symptoms of patients with AS through the regulation of serum biomarkers, and the mechanisms may be associated with the anti‑inflammatory effect, inhibition of new bone formation and potential bone‑protective effects.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Rolle AS, Zimmermann B and Poon SH: Etanercept-induced Henoch-Schönlein purpura in a patient with ankylosing spon-dylitis. J Clin Rheumatol. 19:90–93. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Braun J and Sieper J: Ankylosing spondylitis. Lancet. 369:1379–1390. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Calin A, Brophy S and Blake D: Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet. 354:1687–1690. 1999. View Article : Google Scholar : PubMed/NCBI

4 

Ng SC, Liao Z, Yu DT, et al: Epidemiology of spondyloarthritis in the people’s republic of china: review of the literature and commentary. Semin Arthritis Rheum. 37:39–47. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Rubin LA, Amos CI, Wade JA, et al: Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum. 37:1212–1220. 1994. View Article : Google Scholar : PubMed/NCBI

6 

Zeng QY, Chen R and Darmawan J: Rheumatic diseases In China. Arthritis Res Ther. 10:172008. View Article : Google Scholar

7 

Zochling J and Smith EU: Sero negative spondyloarthritis. Best Pract Res Clin Rheumatol. 24:747–756. 2010. View Article : Google Scholar

8 

Reveille JD: Epidemiology of spondyloarthritis in North America. Am J Med Sci. 341:284–286. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Wendling D, Cedoz JP, Racadot E, et al: Serum IL-17, BMP-7 and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine. 74:304–305. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Mei Y, Pan F, Gao J, et al: Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 30:269–273. 2011. View Article : Google Scholar

11 

Goldberger C, Dulak J, Duftner C, et al: Vascular endothelial growth factor (VEGF) in ankylosing spondylitis-a pilot study. Wien Med Wochenschr. 152:223–225. 2002. View Article : Google Scholar

12 

Samoto H, Shimizu E, Matsuda-Honjyo Y, et al: Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene. J Biol Chem. 278:28659–28667. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Daoussis D, Liossis SN, Solomou EE, et al: Evidence that DKK-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 62:150–158. 2010. View Article : Google Scholar

14 

Maksvmowych WP, Landewé R, Conner-Spady B, et al: Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spon-dylitis. Arthritis Rheum. 56:1846–1853. 2007. View Article : Google Scholar

15 

Christgau S, Garnero P, Fledelius C, et al: Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone. 29:209–215. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Maksvmowych WP: What do biomarkers tell us about the pathogenesis of ankylosing spondylitis? Arthritis Res Ther. 11:1012009. View Article : Google Scholar

17 

van der Linden S, Valkenburg HA and Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27:361–368. 1984. View Article : Google Scholar : PubMed/NCBI

18 

Garrett S, Jenkinson T, Whitelock HC, et al: A new approach to defining disease status in AS: the bath ankylosing spondylitis disease activity index. J Rheumatol. 21:2286–2291. 1994.PubMed/NCBI

19 

Westergren A: Studies of the suspension stability of the blood in pulmonary tuberculosis. Acta Med Scand. 54:247–282. 1921. View Article : Google Scholar

20 

Cansu DU, Calışır C, Savaş Yavaş U, et al: Predictors of radio-graphic severity and functional disability in Turkish patients with ankylosing spondylitis. Clin Rheumatol. 30:557–562. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Maksymowych WP, Morency N, Conner-Spady B, et al: Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis. 72:23–28. 2013. View Article : Google Scholar

22 

Zhang X, Schwarz EM, Young DA, et al: Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 109:1405–1415. 2002. View Article : Google Scholar : PubMed/NCBI

23 

Minear S, Leucht P, Jiang J, et al: Wnt proteins promote bone regeneration. Sci Transl Med. 2:29–30. 2010. View Article : Google Scholar

24 

Lories RJ, Daans M, Derese I, et al: Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum. 54:1736–1746. 2006. View Article : Google Scholar : PubMed/NCBI

25 

O’Gradaigh D, Ireland D, Bord S, et al: Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor α, interleukin 1 and receptor activator of nuclear factor κb ligand (RANKl) regulate osteoclasts. Ann Rheum Dis. 63:354–359. 2004. View Article : Google Scholar

26 

Chen CH, Chen HA, Liao HT, et al: Soluble receptor activator of nuclear factor-kappab ligand (RANKl) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. Clin Rheumatol. 29:1155–1161. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Bao L, Zhu T, Zhao D, et al: Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model. Joint Bone Spine. 79:482–487. 2012. View Article : Google Scholar

28 

Kress BC: Bone alkaline phosphatase: methods of quantitation and clinical utility. J Clin Ligand Assay. 21:139–148. 1998.

29 

Park MC, Chung SJ, Park YB, et al: Bone and cartilage turnover markers, bone mineral density and radiographic damage in men with ankylosing spondylitis. Yonsei Med J. 49:288–294. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Poddubnyy D, Denis Congad, et al: Predictive and protective value of biomarkers in patients with ankylosing spondylitis who are at high risk of radiographic spinal progression. Arthritis Rheum. 63:13382011.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ji W, Chen Y, Zhao X, Guo Y, Zhong L, Li H, Wang D and Song Y: Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis. Mol Med Rep 12: 684-690, 2015.
APA
Ji, W., Chen, Y., Zhao, X., Guo, Y., Zhong, L., Li, H. ... Song, Y. (2015). Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis. Molecular Medicine Reports, 12, 684-690. https://doi.org/10.3892/mmr.2015.3448
MLA
Ji, W., Chen, Y., Zhao, X., Guo, Y., Zhong, L., Li, H., Wang, D., Song, Y."Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis". Molecular Medicine Reports 12.1 (2015): 684-690.
Chicago
Ji, W., Chen, Y., Zhao, X., Guo, Y., Zhong, L., Li, H., Wang, D., Song, Y."Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis". Molecular Medicine Reports 12, no. 1 (2015): 684-690. https://doi.org/10.3892/mmr.2015.3448
Copy and paste a formatted citation
x
Spandidos Publications style
Ji W, Chen Y, Zhao X, Guo Y, Zhong L, Li H, Wang D and Song Y: Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis. Mol Med Rep 12: 684-690, 2015.
APA
Ji, W., Chen, Y., Zhao, X., Guo, Y., Zhong, L., Li, H. ... Song, Y. (2015). Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis. Molecular Medicine Reports, 12, 684-690. https://doi.org/10.3892/mmr.2015.3448
MLA
Ji, W., Chen, Y., Zhao, X., Guo, Y., Zhong, L., Li, H., Wang, D., Song, Y."Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis". Molecular Medicine Reports 12.1 (2015): 684-690.
Chicago
Ji, W., Chen, Y., Zhao, X., Guo, Y., Zhong, L., Li, H., Wang, D., Song, Y."Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis". Molecular Medicine Reports 12, no. 1 (2015): 684-690. https://doi.org/10.3892/mmr.2015.3448
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team